Novartis AGNVSNYSE
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+12.5%
5Y CAGR+5.2%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+12.5%/yr
vs -3.8%/yr prior
5Y CAGR
+5.2%/yr
Recent acceleration
Acceleration
+16.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$1.19B+14.5%
2024$1.04B+18.3%
2023$876.12M+5.0%
2022$834.62M-7.8%
2021$905.00M-1.7%
2020$921.00M+2.0%
2019$902.93M-7.2%
2018$973.22M+21.3%
2017$802.00M+10.0%
2016$729.00M-